Mirae Asset Global ETFs Holdings
OLMA icon

Mirae Asset Global ETFs Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$613K Buy
42,074
+11,806
+39% +$263K ﹤0.01% 1782
2025
Q4 		$757K Buy
30,268
+2,934
+11% +$52.2K ﹤0.01% 1675
2025
Q3 		$268K Buy
+27,334
New +$164K ﹤0.01% 2165
2025
Q2 		– Sell
-23,932
Closed -$90K – 3170
2025
Q1 		$90K Sell
23,932
-2,284
-9% -$11.5K ﹤0.01% 2681
2024
Q4 		$152K Buy
26,216
+724
+3% +$7.23K ﹤0.01% 2523
2024
Q3 		$305K Buy
25,492
+8,636
+51% +$110K ﹤0.01% 2158
2024
Q2 		$184K Buy
+16,856
New +$183K ﹤0.01% 2303

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's OLMA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Olema Pharmaceuticals (OLMA) stake by 39% in Q1 2026, buying an estimated $263K and bringing the position to 42,074 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Mirae Asset Global ETFs Holdings first reported a position in OLMA in Q2 2024 and has held it in 7 quarters since. The position peaked at $757K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 42,074 shares of Olema Pharmaceuticals worth $613K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 11,806 Olema Pharmaceuticals shares in Q1 2026, an estimated $263K.
  • Olema Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1782 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Olema Pharmaceuticals position peaked at $757K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.